Baltic and Eurasia Masterclass in Clinical Oncology
Advanced Breast Cancer: Endocrine Therapy as Preferred Option for HR(+) & Review of CDK4/6 Inhibitors and PIK3CA- Mutant Cohort Trials
Comments 0
Login to view comments.
Click here to Login